MOSES - Prostate Cancer

“Prostate cancer is very treatable and patient numbers continue to grow. In the current care model, new patients are added to the system but are not discharged fast enough to community care when they finish cancer treatment. We need to create capacity in acute cancer centres to see new patients.”

- Chan

There are 211,000 men in Australia currently living with prostate cancer. Prostate cancer is highly treatable with great survival rates leading to an increase of patients with ongoing follow-up care requirements. Research shows a that a shared-care model is feasible in other cancers, such as breast cancer and lymphoma. A pilot trial, ProCare in 2017 suggested no difference in the adherence to testing recommendations and men involved in the study significantly more likely to prefer a shared-care model to hospital follow-up. MOSES is a significantly larger 4-year clinical trial investigating a share-care model in prostate cancer survivors across multiple sites.

Goal

The MOSES trial is expected to include approximately 890 participants across 6 acute cancer centres and involve 900 General Practitioners in Queensland, South Australia, and Victoria over a four-year period.

Aims

To examine the feasibility of a shared-care system in the follow-up of patients treated for prostate cancer across multiple sites nationally.

To expand on the 2017 ProCare pilot trial and provide evidence for practice change.

Researchers

From Flinders

Professor Raymond Chan
Dr Nicolas Hart
Professor Bogda Koczwara

Research Collaborators

Professor Patsy Yates
Dr Ian Vela
Lee Jones
Professor Jeffrey Dunn
Professor Jon Emery
Associate Professor Louisa Gordon
Professor Michael Jefford
Professor Ian Davis
Professor Shomik Sengupta
Dr Carolyn Ee
Professor Elizabeth Halcomb
Associate Professor Joel Rhee
Ms Sally Sara
Professor Karla Hemming
Associate Professor David Pryor
Associate Professor Larisa Haupt
Associate Professor Kim Alexander
Mr Max Shub
Ms Abby Raupach

Grant Details

MRFF Primary Health Care Research Initiative - $1,620,000

Chief Investigators

Professor Raymond Chan Professor Patsy Yates
Dr Ian Vela
Dr Nicolas Hart
Lee Jones
Professor Jeffrey Dunn
Professor Jon Emery
Professor Bogda Koczwara Associate Professor Louisa Gordon
Professor Michael Jefford

Commenced: 2021
Completion due: 2030

Tools and Resources

Collaborators

Queensland University of Technology, University of Melbourne, Prostate Cancer Foundation of Australia, The Council of the Queensland Institute of Medical Research, Peter MacCallum Cancer Centre